[Mutation to inhibitor-resistance and backward mutation to inhibitor-sensitivity in cancer cell cultures].
D000818:Animals; D003470:Culture Media; D046508:Culture Techniques; D005467:Floxuridine / Q000494:pharmacology*; D005998:Glycine / Q000378:metabolism*; D007042:Hypoxanthines / Q000378:metabolism*; D012515:Mast-Cell Sarcoma; D008727:Methotrexate / Q000378:metabolism*; D051379:Mice; D009154:Mutation; D009368:Neoplasm Transplantation; D013936:Thymidine / Q000378:metabolism*
D003470:Culture Media; D007042:Hypoxanthines; D005467:Floxuridine; D005998:Glycine; D013936:Thymidine; D008727:Methotrexate
Mutation zu Hemmstoff-Resistenz und Rückmutation zu Hemmstoff-Empfindlichkeit in Krebszellkulturen.